People who received a personalised melanoma skin cancer vaccine on top of a standard treatment were less likely to die over the study period than those who had the standard treatment alone.
2022
mRNA cancer vaccine combined with Keytruda promising in adjuvant treatment of melanoma
mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, with Keytruda met the primary endpoint of recurrence-free survival in a phase 2b trial for the adjuvant treatment of stage III/IV melanoma after surgical resection.
Drug combination for stage IV melanoma shows success in CU Cancer Center trial
A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.
The pros and cons of local resection of choroidal melanoma
Resection of choroidal tumors is a treatment option but it is technically challenging and more challenging than removing tumors in the iris and ciliary body because the choroid is less accessible.